Albireo Pharma, Inc. (NASDAQ: ALBO) dropped 23.5% to $19.00 after the company reported worse-than-expected Q2 EPS results and filed for a mixed shelf of up to $400 million.
Maxim Group analyst Allen Klee maintains Dolphin Entertainment (NASDAQ: DLPN) with a Buy and lowers the price target from $12 to $10.Maxim Group analyst Allen Klee maintains Dolphin Entertainment (NASDAQ:DLPN) with a Buy and lowers the price target f